Bioequivalence and Bioavailability Forum 06:47 CET

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log in |  Register |  Search

Interference from Deuterated IS [Bioanalytics]

posted by cakhatri - India, 2019-01-10 07:20  - Posting: # 19764
Views: 609

Dear All,

Happy New year

I wish to have inputs on the following issue

1. We are currently working on a Drug-Drug Interaction study where Digoxin is the substrate & X is the Perpetrator.

2.During method development we observed around 12-16% interference from Digoxin deuterated (D3) IS at the RT of Digoxin drug. There seems to be no source for D5 or D7 or D11.

3. Inspite of this interference, all the QCs (100%) (Spiked with only Digoxin & Digoxin + X) are meeting the acceptance criteria.

4. Two different sources of Deuterated IS were tested and results are similar.

5. The LOQ that we have selected is 5% of reported Cmax and there is no possibility to increase the same considering guideline recommendations.

6. Digoxin forms an adduct with Ammonia.

7. The MRM pairs are Drug (798.4 / 651.4) & Digoxin D3 (801.4 / 654.4)

8. Mol.wt for Digoxin is 780.94.


My question

1. Would it be advisable to proceed with the validation and will this have impact during sample analysis since all the samples will be spiked with IS.

2. Is there an alternate approach to this scenario ?

Kind Regards
Chirag

Complete thread:

Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
19,188 posts in 4,084 threads, 1,308 registered users;
online 15 (0 registered, 15 guests [including 11 identified bots]).

The aim of science is not to open the door to infinite wisdom,
but to set a limit to infinite error.    Bertolt Brecht

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5 RSS Feed